LAB vs MSFT: Which Stock is Better?
Side-by-side comparison of Standard Biotools Inc and Microsoft Corp in 2026
LAB
Standard Biotools Inc
$0.93
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | LAB | MSFT | Winner |
|---|---|---|---|
| Market Cap | $360.31M | N/A | LAB |
| P/E Ratio | N/A | 26.31 | MSFT |
| EPS (TTM) | $N/A | $16.07 | MSFT |
| Revenue Growth | -0.0% | 0.2% | MSFT |
| Gross Margin | 49.9% | 68.6% | MSFT |
Analyze LAB
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LAB or MSFT a better investment?
Comparing LAB and MSFT: Standard Biotools Inc has a market cap of $360.31M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LAB and MSFT?
LAB (Standard Biotools Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LAB or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LAB or MSFT?
MSFT has higher revenue growth at 0.2% vs -0.0% for LAB.
Which company is more profitable: LAB or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 49.9% for LAB.
Which is the larger company: LAB or MSFT?
Standard Biotools Inc (LAB) is larger with a market cap of $360.31M compared to N/A for MSFT.
Should I buy LAB or MSFT in 2026?
Both LAB and MSFT have investment merit. LAB trades at $0.93 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LAB and MSFT stock?
Key differences: Market Cap ($360.31M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (-0.0% vs 0.2%), Gross Margin (49.9% vs 68.6%).